Report Detail

Agriculture Global Aujeszky Disease Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3811520
  • |
  • 19 August, 2024
  • |
  • Global
  • |
  • 134 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Agriculture

According to our (Global Info Research) latest study, the global Aujeszky Disease Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Aujeszky disease vaccines, also known as pseudorabies vaccines, are vaccines developed to prevent Aujeszky disease, which is a contagious viral disease primarily affecting pigs. The disease is caused by the suid herpesvirus 1 (SuHV-1), also known as pseudorabies virus (PRV).
The prevalence of Aujeszky Disease in swine populations can impact the demand for vaccines. Higher disease incidence may drive increased vaccination efforts to control and prevent outbreaks.
The Global Info Research report includes an overview of the development of the Aujeszky Disease Vaccines industry chain, the market status of Sow (Inactivated Vaccine, Naturally Missing Attenuated Virus Vaccine), Piggy (Inactivated Vaccine, Naturally Missing Attenuated Virus Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Aujeszky Disease Vaccines.
Regionally, the report analyzes the Aujeszky Disease Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Aujeszky Disease Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Aujeszky Disease Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Aujeszky Disease Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Vaccine, Naturally Missing Attenuated Virus Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Aujeszky Disease Vaccines market.
Regional Analysis: The report involves examining the Aujeszky Disease Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Aujeszky Disease Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Aujeszky Disease Vaccines:
Company Analysis: Report covers individual Aujeszky Disease Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Aujeszky Disease Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Sow, Piggy).
Technology Analysis: Report covers specific technologies relevant to Aujeszky Disease Vaccines. It assesses the current state, advancements, and potential future developments in Aujeszky Disease Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Aujeszky Disease Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Aujeszky Disease Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Inactivated Vaccine
Naturally Missing Attenuated Virus Vaccine
Artificially Missing Attenuated Virus Vaccine
Market segment by Application
Sow
Piggy
Boar
Major players covered
IDEXX
Ceva
MSD Animal Health
Kyoritsuseiyaku Corporation
CAVAC
HIPRA
Zendal group(CZ Vaccines)
Wuhan Keqian Biology
Boehringer Ingelheim
HIPRA
China Animal Husbandry Industry
Harvac
MERIAL
ZHAO FENG HUA
Ahdivinity
Shanghai Hile Bio-Tech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aujeszky Disease Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aujeszky Disease Vaccines, with price, sales, revenue and global market share of Aujeszky Disease Vaccines from 2019 to 2024.
Chapter 3, the Aujeszky Disease Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aujeszky Disease Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Aujeszky Disease Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aujeszky Disease Vaccines.
Chapter 14 and 15, to describe Aujeszky Disease Vaccines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Aujeszky Disease Vaccines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Inactivated Vaccine
    • 1.3.3 Naturally Missing Attenuated Virus Vaccine
    • 1.3.4 Artificially Missing Attenuated Virus Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Sow
    • 1.4.3 Piggy
    • 1.4.4 Boar
  • 1.5 Global Aujeszky Disease Vaccines Market Size & Forecast
    • 1.5.1 Global Aujeszky Disease Vaccines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Aujeszky Disease Vaccines Sales Quantity (2019-2030)
    • 1.5.3 Global Aujeszky Disease Vaccines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 IDEXX
    • 2.1.1 IDEXX Details
    • 2.1.2 IDEXX Major Business
    • 2.1.3 IDEXX Aujeszky Disease Vaccines Product and Services
    • 2.1.4 IDEXX Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 IDEXX Recent Developments/Updates
  • 2.2 Ceva
    • 2.2.1 Ceva Details
    • 2.2.2 Ceva Major Business
    • 2.2.3 Ceva Aujeszky Disease Vaccines Product and Services
    • 2.2.4 Ceva Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Ceva Recent Developments/Updates
  • 2.3 MSD Animal Health
    • 2.3.1 MSD Animal Health Details
    • 2.3.2 MSD Animal Health Major Business
    • 2.3.3 MSD Animal Health Aujeszky Disease Vaccines Product and Services
    • 2.3.4 MSD Animal Health Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 MSD Animal Health Recent Developments/Updates
  • 2.4 Kyoritsuseiyaku Corporation
    • 2.4.1 Kyoritsuseiyaku Corporation Details
    • 2.4.2 Kyoritsuseiyaku Corporation Major Business
    • 2.4.3 Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Product and Services
    • 2.4.4 Kyoritsuseiyaku Corporation Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Kyoritsuseiyaku Corporation Recent Developments/Updates
  • 2.5 CAVAC
    • 2.5.1 CAVAC Details
    • 2.5.2 CAVAC Major Business
    • 2.5.3 CAVAC Aujeszky Disease Vaccines Product and Services
    • 2.5.4 CAVAC Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 CAVAC Recent Developments/Updates
  • 2.6 HIPRA
    • 2.6.1 HIPRA Details
    • 2.6.2 HIPRA Major Business
    • 2.6.3 HIPRA Aujeszky Disease Vaccines Product and Services
    • 2.6.4 HIPRA Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 HIPRA Recent Developments/Updates
  • 2.7 Zendal group(CZ Vaccines)
    • 2.7.1 Zendal group(CZ Vaccines) Details
    • 2.7.2 Zendal group(CZ Vaccines) Major Business
    • 2.7.3 Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Product and Services
    • 2.7.4 Zendal group(CZ Vaccines) Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Zendal group(CZ Vaccines) Recent Developments/Updates
  • 2.8 Wuhan Keqian Biology
    • 2.8.1 Wuhan Keqian Biology Details
    • 2.8.2 Wuhan Keqian Biology Major Business
    • 2.8.3 Wuhan Keqian Biology Aujeszky Disease Vaccines Product and Services
    • 2.8.4 Wuhan Keqian Biology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Wuhan Keqian Biology Recent Developments/Updates
  • 2.9 Boehringer Ingelheim
    • 2.9.1 Boehringer Ingelheim Details
    • 2.9.2 Boehringer Ingelheim Major Business
    • 2.9.3 Boehringer Ingelheim Aujeszky Disease Vaccines Product and Services
    • 2.9.4 Boehringer Ingelheim Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.10 HIPRA
    • 2.10.1 HIPRA Details
    • 2.10.2 HIPRA Major Business
    • 2.10.3 HIPRA Aujeszky Disease Vaccines Product and Services
    • 2.10.4 HIPRA Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 HIPRA Recent Developments/Updates
  • 2.11 China Animal Husbandry Industry
    • 2.11.1 China Animal Husbandry Industry Details
    • 2.11.2 China Animal Husbandry Industry Major Business
    • 2.11.3 China Animal Husbandry Industry Aujeszky Disease Vaccines Product and Services
    • 2.11.4 China Animal Husbandry Industry Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 China Animal Husbandry Industry Recent Developments/Updates
  • 2.12 Harvac
    • 2.12.1 Harvac Details
    • 2.12.2 Harvac Major Business
    • 2.12.3 Harvac Aujeszky Disease Vaccines Product and Services
    • 2.12.4 Harvac Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Harvac Recent Developments/Updates
  • 2.13 MERIAL
    • 2.13.1 MERIAL Details
    • 2.13.2 MERIAL Major Business
    • 2.13.3 MERIAL Aujeszky Disease Vaccines Product and Services
    • 2.13.4 MERIAL Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 MERIAL Recent Developments/Updates
  • 2.14 ZHAO FENG HUA
    • 2.14.1 ZHAO FENG HUA Details
    • 2.14.2 ZHAO FENG HUA Major Business
    • 2.14.3 ZHAO FENG HUA Aujeszky Disease Vaccines Product and Services
    • 2.14.4 ZHAO FENG HUA Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 ZHAO FENG HUA Recent Developments/Updates
  • 2.15 Ahdivinity
    • 2.15.1 Ahdivinity Details
    • 2.15.2 Ahdivinity Major Business
    • 2.15.3 Ahdivinity Aujeszky Disease Vaccines Product and Services
    • 2.15.4 Ahdivinity Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Ahdivinity Recent Developments/Updates
  • 2.16 Shanghai Hile Bio-Tech
    • 2.16.1 Shanghai Hile Bio-Tech Details
    • 2.16.2 Shanghai Hile Bio-Tech Major Business
    • 2.16.3 Shanghai Hile Bio-Tech Aujeszky Disease Vaccines Product and Services
    • 2.16.4 Shanghai Hile Bio-Tech Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Shanghai Hile Bio-Tech Recent Developments/Updates

3 Competitive Environment: Aujeszky Disease Vaccines by Manufacturer

  • 3.1 Global Aujeszky Disease Vaccines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Aujeszky Disease Vaccines Revenue by Manufacturer (2019-2024)
  • 3.3 Global Aujeszky Disease Vaccines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Aujeszky Disease Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Aujeszky Disease Vaccines Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Aujeszky Disease Vaccines Manufacturer Market Share in 2023
  • 3.5 Aujeszky Disease Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Aujeszky Disease Vaccines Market: Region Footprint
    • 3.5.2 Aujeszky Disease Vaccines Market: Company Product Type Footprint
    • 3.5.3 Aujeszky Disease Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Aujeszky Disease Vaccines Market Size by Region
    • 4.1.1 Global Aujeszky Disease Vaccines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Aujeszky Disease Vaccines Consumption Value by Region (2019-2030)
    • 4.1.3 Global Aujeszky Disease Vaccines Average Price by Region (2019-2030)
  • 4.2 North America Aujeszky Disease Vaccines Consumption Value (2019-2030)
  • 4.3 Europe Aujeszky Disease Vaccines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Aujeszky Disease Vaccines Consumption Value (2019-2030)
  • 4.5 South America Aujeszky Disease Vaccines Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Aujeszky Disease Vaccines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 5.2 Global Aujeszky Disease Vaccines Consumption Value by Type (2019-2030)
  • 5.3 Global Aujeszky Disease Vaccines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 6.2 Global Aujeszky Disease Vaccines Consumption Value by Application (2019-2030)
  • 6.3 Global Aujeszky Disease Vaccines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 7.2 North America Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 7.3 North America Aujeszky Disease Vaccines Market Size by Country
    • 7.3.1 North America Aujeszky Disease Vaccines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Aujeszky Disease Vaccines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 8.2 Europe Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 8.3 Europe Aujeszky Disease Vaccines Market Size by Country
    • 8.3.1 Europe Aujeszky Disease Vaccines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Aujeszky Disease Vaccines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Aujeszky Disease Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 10.2 South America Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 10.3 South America Aujeszky Disease Vaccines Market Size by Country
    • 10.3.1 South America Aujeszky Disease Vaccines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Aujeszky Disease Vaccines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Aujeszky Disease Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Aujeszky Disease Vaccines Market Drivers
  • 12.2 Aujeszky Disease Vaccines Market Restraints
  • 12.3 Aujeszky Disease Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Aujeszky Disease Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Aujeszky Disease Vaccines
  • 13.3 Aujeszky Disease Vaccines Production Process
  • 13.4 Aujeszky Disease Vaccines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Aujeszky Disease Vaccines Typical Distributors
  • 14.3 Aujeszky Disease Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Aujeszky Disease Vaccines. Industry analysis & Market Report on Aujeszky Disease Vaccines is a syndicated market report, published as Global Aujeszky Disease Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Aujeszky Disease Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report